India authorizes export of Covovax doses to three foreign countries
The Indian government has authorized the export of seven crore doses of the Covid Covovax vaccine produced by the Serum Institute of India to the Netherlands, Australia and New Zealand, official sources announced today.
The Serum Institute had submitted a request to the Comptroller General of Medicines of India (DCGI) for permission to export vaccine doses to foreign countries, official sources said.
“After evaluation, the DCGI office has given the green light for the export of seven crore doses of Covovax to the Netherlands, Australia and New Zealand,” they said.
This vaccine is not yet approved in these countries.
India’s central drug authority CDSCO on Tuesday approved Covovax for restricted use in emergency situations in the country. The DCGI office authorized SII to manufacture and store the Covovax on May 17. Based on DCGI’s approval, so far the Pune-based company has manufactured and stored the vaccine doses, they said.
The World Health Organization published an emergency use list for Covovax on December 17, expanding the basket of jabs validated by the world health organization against viral disease.
The Center had authorized the export of two crore doses of Covovax to Indonesia in November before the Indian authorization for emergency use.